Related Experiment Video
Updated: Apr 20, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.6K
[Personalized medicine: an elusive concept, diversified practices]
1Centre de recherche médecine, sciences, santé, santé mentale, société (CERMES3), CNRS UMR 8211, Université Paris Descartes, EHESS, Inserm U988, Campus CNRS de Villejuif, 7, rue Guy Môquet, 94801 Villejuif, Cedex, France.
Medecine Sciences : M/S
|November 20, 2014
Summary
Personalized medicine uses technology and big data, focusing on patient group differences for better diagnoses and treatments, not individual uniqueness.
Area of Science:
- Genomics and Bioinformatics
- Medical Informatics
- Precision Medicine
Context:
- Growing integration of advanced technologies in healthcare.
- Increasing emphasis on data-driven medical decision-making.
- The rise of genomics and large-scale data collection in research.
Purpose:
- To analyze the core components and underlying principles of personalized medicine.
- To investigate the role of technology, genetics, and data in modern medical practices.
- To clarify the focus of personalized medicine on inter-patient variability rather than individual uniqueness.
Summary:
- Personalized medicine is characterized by technology-driven, data-intensive healthcare, with genetics and genomics playing a central role.
- It focuses on identifying differences among patient categories to refine diagnostic, therapeutic, and preventive strategies.
- The approach leverages objective biological data to enhance medical tools and improve patient outcomes.
Impact:
- Potential to significantly improve diagnostic accuracy and therapeutic efficacy.
- Enables more targeted and effective preventive healthcare strategies.
- Advances the field of precision medicine through objective, data-driven insights.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:50Combination Therapies and Personalized Medicine
1.9K
1.9K
01:29Pharmacogenetics and Pharmacogenomics: Overview
216
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
216
01:24Dosage Regimen: Individualization
378
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
378
01:29Pharmacogenomics: Identification of New Drug Targets
108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
142
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
142